CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA
Article
Grommes, Christian, Mehta, Minesh, Miller, Alexandra et al. (2020). CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA
. NEURO-ONCOLOGY, 22(Supplement_2), ii36-ii36. 10.1093/neuonc/noaa215.149
Grommes, Christian, Mehta, Minesh, Miller, Alexandra et al. (2020). CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA
. NEURO-ONCOLOGY, 22(Supplement_2), ii36-ii36. 10.1093/neuonc/noaa215.149